Drug Type Small molecule drug |
Synonyms TP 0542354, TP-0542354 |
Target |
Action inhibitors |
Mechanism LpxC inhibitors(UDP-3-O-acyl-N-acetylglucosamine deacetylase inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseDiscontinuedPreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Gram-Negative Bacterial Infections | Preclinical | Japan | - | |
| Gram-Negative Bacterial Infections | Preclinical | United Kingdom | - |





